Introduction
Several techniques for the non-invasive determination of haemodynamic parameters such as cardiac output (CO) and stroke volume (SV) have been proposed and evaluated in recent years. Impedance cardiography (ICG) is particularly interesting since it is easy to perform, inexpensive and does not require patient cooperation. After its introduction by Kubicek and colleagues in the 1960s 1 , several factors influencing the accuracy such as changes in intrathoracic water content, arrhythmias, movement artefacts or anatomical characteristics were soon identified [2] [3] [4] . As a consequence, the original formula has been repeatedly refined leading to numerous algorithms and devices on the market.
Two of the latest adaptions are referred to as Bioreactance® (BR) incorporated in the NICOM® (Cheetah Medical, Newton Center, MA, USA) device on the one hand, and electrical velocimetry (EV) used in the Aesculon® Cardiac Output Monitor (Osypka Medical, Berlin, Germany) on the other. Although both are based on thoracic impedance measurements, the algorithms differ fundamentally in construction of the flow signal. Electrical velocimetry uses the amplitude component of thoracic impedance as described in the original ICG approach; however, it additionally relates the maximum rate of change of impedance to peak aortic blood acceleration. In contrast, BR derives haemodynamic data from the phase shift, which is presumed to be more robust against movement artefacts, electrode positioning, and different anatomical characteristics. With the overwhelming majority of thoracic pulsatile flow coming from the aorta, the BR signal can be almost completely attributed to aortic flow.
Electrical velocimetry yielded diverging results when being compared to invasive [7] [8] [9] as well as non-invasive [10] [11] [12] reference techniques. An overall insufficient agreement was found with cardiac magnetic resonance imaging (CMR), while an increasing CO and SV as well as gender and height were associated with an increased bias 12 . Available data for BR are also inconsistent, with some studies showing promising results [13] [14] [15] [16] , while others have not confirmed these findings [17] [18] [19] . However, no comparison with CMR as the novel non-invasive gold standard for determination of cardiac function 20 has been performed yet.
The aim of our prospective study therefore was to assess the accuracy and reproducibility of CO measurements obtained by BR, and to identify factors associated with larger variation. Reference values were determined using CMR.
Materials and methods

Subjects
We initially included 41 stable patients with independent indications for CMR after written informed consent was obtained. One patient had to be excluded due to invalid BR measurements. The CMR measurement was not possible or showed moderate to severe aortic or mitral valve disease in eight patients. The final data analysis was thus performed in 32 patients. Concomitant diseases included systemic hypertension (47%), mild mitral valve disease (31%), and coronary artery disease (28%) ( Table 1 ). The study protocol was approved by our institutional Ethics Committee (approval number 2006-189N-MA) and registered at clinicaltrials.gov (NCT02331329).
Study protocol
All measurements were conducted by physicians and technicians experienced in BR and CMR and blinded to the results obtained by the alternative method. The BR measurements were performed either before or after the CMR examination following 10 minutes of rest with the patient in a stable supine position. Average values over a period of 30 seconds were used. To calculate reproducibility, measurements were performed twice at an interval of five minutes with the patient remaining in an unchanged position. Four proprietary sensor pads were applied at defined positions on both sides of the upper and lower anterior trunk respectively. Signal quality was verified by visualisation of the electrocardiographic (ECG) and impedance waveforms.
Bioreactance
Bioreactance CO was determined using NICOM, which implements a newly developed algorithm referred to as Bioreactance. A high frequency (75 kHz) and low-amperage alternating electrical current is applied to the thorax using the respective outer one of two electrodes integrated in each of the four sensor pads. The signals are then received via the inner electrodes of the pads and the resulting phase shift (Φ) between the amplitude of the applied current and received voltage is calculated (Figure 1 left) . The continuously recorded Φ are then converted to a signal (Figure 1 , middle) correlated to pulsatile changes in fluid volume. Since flow is the change of volume over time, the flow signal is obtained by deriving the fluid volume signal in time (Figure 1, right) . The maximum flow (dΦ/dt max ) is measured by the maximum point and while dΦ/dt is proportional to SV, it can hence be calculated as: SV = dΦ/dt x VET x c where the ventricular ejection time (VET) is defined from the first zero crossing to the second zero crossing. Since dΦ/dt is influenced by the propagation of the signal in the thorax, anatomical characteristics should be taken into account. This is done by assigning a patient-specific constant of proportionality, c, taking weight, height and age into account. Finally, CO can be calculated by multiplication of SV by heart rate.
Cardiac magnetic resonance imaging
Determination of CO by CMR was performed on a 1.5 Tesla whole-body imaging system (Magnetom Sonata, Siemens Medical Systems, Erlangen, Germany). Images were acquired during repeated end-expiratory breath-holds and analysed offline using dedicated software (ARGUS, Siemens). ECGgated cine images were then acquired using a segmented steady state free precession sequence (TrueFISP). Patients with moderate and severe aortic or mitral valve disease were designated to be excluded, as volume-based haemodynamic CMR measurements may be impaired. Valve status was assessed qualitatively. Three long-axis views and seven to 12 short-axis views covering the whole left ventricle were averaged over multiple heart cycles depending on heart rate. End-diastole and end-systole were defined as the frame showing the largest and smallest cavity area, respectively. Epicardial and endocardial contours were outlined manually once on each end-diastolic and end-systolic short-axis frame including papillary muscles in left ventricular cavity volumes 21 .
Total end-diastolic and end-systolic cavity volumes were computed using a modified Simpson's rule equation. Stroke volume was calculated as the difference between enddiastolic and end-systolic volumes; the product of SV and heart rate was defined as CO.
Statistical analysis
Comparison of haemodynamic variables was performed as proposed by Bland and Altman to avoid the methodological problems introduced by correlation coefficients and regression analysis 23 . Mean difference, standard deviation (SD) of the differences as well as upper and lower limits of agreement (± 1.96 x standard deviation [SD]) were calculated. The CMR measurements served as reference, being compared to the arithmetic mean of two repeated BR measurements. Agreement and reproducibility was assessed as proposed by Critchley and Critchley 23 with limits of agreement not exceeding ±30% defined as acceptable. A 20% variability of repeated measurements using BR was also defined as acceptable. Student's t-test for independent samples and Pearson product-moment correlation coefficient was used. Correlation coefficients were interpreted as proposed by Evans 24 regarding values of less than 0.20 as very weak, 0.20 to 0.39 as weak, 0.40 to 0.59 as moderate, 0.60 to 0.79 as strong and 0.80 or greater as very strong relationships. Comparison between circulatory condition classes was accomplished using analyses of variances (ANOVA). All data are presented as mean ± SD and a P-value less than 0.05 was considered statistically significant.
Results
Mean CO as determined by CMR (CO CMR ) was 6.6 ± 2.3 l/minute ranging from 3.1 to 12.5 l/minute. Repeated BR measurements yielded a mean CO (CO BR ) of 6.4 ± 1.6 l/minute ranging from 4.0 to 10.2 l/minute. Detailed information on baseline characteristics and haemodynamic data is given in Table 2 . Using Bland-Altman analysis we found a mean bias of 0.2 ± 1.8 l/minute (1 ± 28%) with wide limits of agreement ranging from -3.4 to 3.7 l/minute ( Figure  2A ). The correlation coefficient was r = 0.62 (P <0.001) indicating a strong relationship. Reproducibility was acceptable with a mean bias of 0.1 ± 0.9 l/minute (1 ± 14%) and a coefficient of variation equalling 10% ( Figure  2B ). Very strong correlation was found between repeated measurements (r = 0.83, P <0.0001). The percentage errors were 55% and 27% for accuracy and reproducibility, respectively. We stratified the collective data into thirds according to CO CMR to further investigate low and high cardiac output states. We found a better agreement with a mean bias of 0.3 ± 1.3 l/minute in the middle third representing CO values between 5.3 and 6.3 l/minute. In patients with low cardiac output states, CO was significantly overestimated by BR (-1.1 ± 1.5 l/minute), while high cardiac output states were underestimated (1.5 ± 1.7 l/minute) (P=0.001), ( Figure  3A) . Reproducibility was not negatively affected by a high or low CO CMR ( Figure 3B ). No differences between men and women could be identified for accuracy (0.0 ± 2.0 versus 0.5 ± 1.5 l/minute, P=0.48) or reproducibility (0.0 ± 1.0 versus -0.1 ± 0.8 l/minute, P=0.76). However, we found a moderate, yet significant correlation between bias and weight (r = 0.50, P=0.02) in men, while no correlation was found in women (r = -0.10, P=0.77). Reproducibility was neither significantly correlated with weight in men (r = 0.32, P=0.16) nor women (r = -0.04, P=0.91), respectively. Neither gender showed a significant correlation of height with accuracy (men r = 0.11, P=0.64, women r = -0.20, P=0.55). There was no significant correlation between height and reproducibility in women (r = -0.59, P=0.07) or men (r = 0.15, P=0.51). When evaluating nine patients with arrhythmia during the BR measurement, significant differences were not found for accuracy (0.3 ± 1.4 versus 0.1 ± 2.0 l/minute, P=0.76) or reproducibility (0.0 ± 1.2 versus -0.1 ± 0.9 l/minute, P=0.88) as compared to controls in sinus rhythm. Bias tended to be larger, although not significant, in patients with mild mitral regurgitation (0.7 ± 1.5 l/minute, P=0.13) while mild aortic valve disease was associated with a significantly larger bias (1.9 ± 2.2 l/minute, P=0.02) as compared to patients without valve disease (-0.3 ± 1.7 l/minute).
Discussion
We found an overall insufficient agreement between CMR and BR cardiac output measurements in our sample of haemodynamically stable patients. Despite the satisfactory mean bias, limits of agreement exceeded current recommendations 23 . Similar results were found in previous studies investigating different clinical situations and using different reference techniques. For example, Kupersztych-Hagege and co-workers found an insufficient agreement when comparing BR to thermodilution in a medical intensive care unit 19 . In patients undergoing cytoreductive surgery in ovarian carcinoma, similar inaccuracies were seen 18 . Han and co-workers stated that BR was not able to estimate CO or track changes in patients undergoing liver transplantation 17 . In contrast, in a study limited to 20 intensive care patients following cardiac surgery, good agreement with invasive pulse wave analysis calibrated by trans-cardiopulmonary thermodilution could be demonstrated during lung recruitment manoeuvres 14 . Similarly, an acceptable agreement could be demonstrated by the same study group in a larger cohort as compared to pulmonary arterial thermodilution 15 . Raval and co-workers could demonstrate an acceptable accuracy in a multicentre evaluation of challenging clinical environments such as intensive care units and cardiac catheterisation laboratories 13 .
Since extreme cardiac output states are a known impediment to the novel non-invasive techniques, we further stratified the collective in thirds according to CO CMR . For CO values in the physiological range we found a better agreement and acceptable limits of agreement. Extreme cardiac output states showed a significantly worse agreement, overestimating low and underestimating high CO values, respectively. Similar findings were seen for both the novel techniques such as EV, inert gas rebreathing, pulse contour analysis (PCA) and continuous wave Doppler 12,25-28 as well as for the clinical gold standard thermodilution itself [29] [30] [31] . Impedance techniques directly or indirectly include individual patient characteristics such as weight, height, age and gender in their respective algorithms, while in our study, weight was associated with an increased bias in men in BR measurements. Inaccuracies in the underlying algorithm could be a possible explanation and were previously also suspected for similar effects in EV measurements 12 . This is supported by previous findings where introduction of a weight correction factor significantly influenced the accuracy of the Sramek and Bernstein ICG algorithm 32 . Interestingly, the original Kubicek formula was not biased by weight. Other factors such as electrode positioning were investigated for neither BR nor EV to date, although BR is presumed to be robust as the phase does not change depending on the location on the thorax. Taken together, both impedance techniques showed comparably wide limits of agreement with a remarkably lower mean bias for BR as compared to EV. Nevertheless, further investigation of other factors influencing the measurement accuracy, and potentially refining algorithms, is still lacking.
We found acceptable reproducibility for BR measurements in our sample, which was not negatively affected by gender, height, weight or high or low cardiac output states. Assessing the reproducibility is important since it provides information about the ability of a method to track haemodynamic changes. Short-term haemodynamic effects are the predominant measurement target in the intensive care setting evaluating, for example, vasopressor therapy or fluid resuscitation. The evaluation of long-term haemodynamic effects includes therapeutic response to drug or device interventions as well as risk stratification, e.g. in pulmonary arterial hypertension or heart failure. While no direct statements on the responsiveness of BR can be derived from our data, previous investigations came to contradictory results. Data from a surgical intensive care unit demonstrated even better reproducibility for BR than for pulmonary arterial thermodilution with a good responsiveness over a wide range of cardiac output states 15 . Fluid responsiveness could also be predicted from changes in CO due to a passive leg raise test in adult patients after cardiac surgery 33 as well as in haemodynamically unstable conditions 34 . In patients with pulmonary hypertension BR was able to track haemodynamic changes during vasodilator challenge as compared to Fick measurements 35 . Despite a remarkably low correlation coefficient, an acceptable trending ability was described by Kober and co-workers 18 . Contrary to these findings, BR failed to predict volume responsiveness in critically ill patients 19 and could not track haemodynamic changes in patients undergoing liver transplantation 17 .
When evaluating critically ill patients several factors may contribute to larger variations of BR. For example in sepsis an appreciable portion of continuous rather than pulsatile flow may lead to inaccuracies when the pulsatile component during systole is considered for measurements 2 . This could also be the case during cardiac surgery using a heart-lung machine or in patients with mechanical devices such as an intra-aortic balloon pump or left ventricular assist device. Although changes in intrathoracic fluid content are a known impediment to ICG in general, it has been assumed that neither the underlying levels of thoracic fluid nor their changes induce any phase shifts and consequently do not contribute to the NICOM signal. Moreover, signal averaging is said to make the method accurate in patients with arrhythmias 36 . This is in accordance with our findings evaluating nine patients with arrhythmia during the BR measurement; however, the subgroup of this post hoc analysis is rather small and therefore lacking statistical power. Since valvular regurgitation alters the transthoracic impedance cardiogram 37, 38 , BR haemodynamic measurements could also be potentially impaired. Although we performed subgroup analysis we cannot draw firm conclusions about mild valve disease due to the small subgroups and post hoc nature of the analysis. While electrocautery interferes with the BR signal, CO values can still be used when receiving a signal for at least 20 seconds within a minute 36 . With haemodynamic measurements being especially valuable under exercise conditions, concerns have been raised for ICG in general due to movement artefacts. Phase shifts were postulated to be less sensitive to body motion than conventional amplitude-based impedance measurements. Jones and co-workers could demonstrate the feasibility and good test-retest reliability during different stages of graded exercise testing. However, their conclusions were restricted to a small collective of healthy volunteers and no reference technique was used. Previously, peak cardiac power measured using BR was found to add independent prognostic information to peak VO 2 in subjects with advanced heart failure in a large collective of 127 patients 40 .
Limitations
The main limitation of our finding is related to the small sample of 32 patients. Nevertheless, we believe our results are valuable for the evaluation of BR, because it was compared to a non-invasive gold standard for the first time. Despite the rather small numbers, especially in the subgroups, we found a large variation of accuracy indicating a lack of clinically acceptable agreement. Simultaneous measurements of BR and CMR would have been desirable to exclude haemodynamic CO changes occurring between the measurements but for both technical and clinical reasons this was not possible. Nevertheless, because both measurements were taken during stable periods, similar circulatory conditions can be assumed. The volume-based haemodynamic CMR measurements may be impaired by backward flow caused by mitral or aortic regurgitation. Thus, we had to exclude a considerable number of patients depending on the respective CMR findings and we cannot draw conclusions on the influence of severe mitral or aortic valve defects on BR. No information on trending can be drawn from our investigation, while again the variation of repeated measurements suggests deficiencies of BR. We also performed multiple comparisons, so individual P-values should be interpreted with caution. Negative findings must be interpreted with particular caution, due to the small numbers and inadequate power, to reliably evaluate real differences.
Conclusion
Bioreactance CO measurements showed an overall insufficient agreement with CMR, exceeding limits of agreement in current recommendations. Reproducibility was acceptable and not negatively affected by circulatory conditions. Low cardiac output states were significantly overestimated while high cardiac output states were underestimated. Moreover, there was a moderate correlation between bias and weight in men. Consequently, absolute CO values acquired with BR should be interpreted with caution and must not be used interchangeably in clinical practice.
